HC Wainwright & Co. Downgrades CytoSorbents to Neutral, Lowers Price Target to $1
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Sean Lee downgraded CytoSorbents (CTSO) from Buy to Neutral and reduced the price target from $5.5 to $1, indicating a more cautious outlook on the company's stock.
December 29, 2023 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CytoSorbents' stock may face downward pressure after HC Wainwright & Co.'s downgrade from Buy to Neutral and a significant price target reduction from $5.5 to $1.
Analyst downgrades typically lead to negative sentiment among investors, and a substantial decrease in the price target suggests a bearish outlook on the stock's value, which could result in short-term price decline.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100